GLAXOSMITHKLINE RESERVES $2.36 BILLION FOR AVANDIA SETTLEMENTS | Dallas, Texas Personal Injury Attorney Blog
GlaxoSmithKline (GSK) CEO Andrew Witty announced that GlaxoSmithKline is under investigation from the Justice Department and several states for actions related to the development and marketing of its diabetes drug Avandia. The company is responding to a subpoena from Justice as well as civil investigative demands from numerous state attorneys general, the company said Thursday. GSK took a $2.36 billion charge against its earnings in the second quarter of this year to settle litigation related to Avandia (rosiglitazone), but now it has been hit with more lawsuits over the drug,
Meanwhile GlaxoSmithKline (GSK) and the Justice Department have finalized a settlement agreement in which the UK drugmaker will pay $750 million to settle an investigation into a now-shuttered Puerto Rico facility where adulterated drugs were made.
LEGAL RIGHTS OF PATIENTS INJURED BY AVANDIA
The law in most states provides several personal injury claims for persons who have been seriously injured by a prescription drug with excessive and dangerous side effects. These claims include strict liability for a defective product, breach of warranty, negligence, and misrepresentation. Damages sought against pharmaceutical companies for dangerous drug side effects and injuries include at least the following types of damages:
- Physical pain and suffering, mental anguish;
- Physical impairment;
- Medical expenses associated with efforts to remedy the injuries as a result of the original surgery;
- Loss of earnings and/or earning capacity; and
- In the case of a patient’s death, the family of the victim may file a wrongful death action and seek damages.
Montes Herald Law Group, L.L.P.
Attorneys: Rachel Montes and Tom Herald
1121 Kinwest Parkway, Suite 100
Irving, Texas 75063
Telephone (214) 522-9401
Toll Free (877) 529-8899
Facebook @ Montes Herald Law Group, L.L.P.